| Literature DB >> 33975535 |
Adrien Rougny1,2, Loïc Paulevé3, Michèle Teboul4, Franck Delaunay5.
Abstract
BACKGROUND: The temporal coordination of biological processes by the circadian clock is an important mechanism, and its disruption has negative health outcomes, including cancer. Experimental and theoretical evidence suggests that the oscillators driving the circadian clock and the cell cycle are coupled through phase locking.Entities:
Keywords: Biological oscillators; Boolean modelling; Cell cycle checkpoints; Control; Model checking; Reaction maps; SBGN
Mesh:
Year: 2021 PMID: 33975535 PMCID: PMC8114686 DOI: 10.1186/s12859-021-04158-9
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Fig. 1Detailed view of the NR1D1 subnetwork, visualized in CellDesigner. The subnetwork is represented using the CellDesigner format [33], which is compatible with the SBGN Process Description language [26]
Summary of experimentally validated molecular interactions between the circadian clock and the mammalian cell cycle molecular networks
| Clock | Cell cycle | Phase | Mechanism | Output | Ref. | |
|---|---|---|---|---|---|---|
| ARNTL:CLOCK | G2/M | Transcriptional | Activation | [ | ||
| NR1D1 | G1 | Transcriptional | Repression | [ | ||
| RORG | G1 | Transcriptional | Activation | [ | ||
| NONO | G1 | Transcriptional | Activation | [ | ||
| NR1D1 | CDK1 | G2/M | Phosphorylation | Degradation | [ | |
| PER1 | CHEK2:ATM | S | Complex formation | DNA damage induced apoptosis | [ | |
| CRY2:TIM | CHEK2:ATM | S | Complex formation | Defective intra-S checkpoint | [ | |
| PER2 | TP53 | S | Nuclear translocation | Stabilisation | [ |
Arrows represent the direction of the influences (: from the circadian clock to cell cycle; : from the cell cycle to the circadian clock). All reported interactions have evidence in the literature
Fig. 2Illustration of the qualitative validations and predictions performed on the dynamical model. A precursor state is composed of the least number of entities to be “present” (represented in blue) so that all processes of the map can be “switched on” in the future. a For a given phase N, we check for the existence of trajectories from a precursor state leading to a state where at least one marker of that phase phase is “present” and all markers of all other phases are “absent”. b Same as in a, but using a model where all markers of the phase directly preceding phase N (i.e., of phase N − 1) are disabled by a Loss-of-Function (LoF). c For a given phase N and a given marker of that phase, we compute the mutations [Loss-of-Function (LoF) or Gain-of-Function (GoF)] that prevent the existence of trajectories leading to a state where this marker is “present”
Markers of the phases of the cell cycle
| Phase | Marker | Compartment |
|---|---|---|
| early G1 | CCND1:CDK6(P@Thr):CDKN1B | Nucleoplasm |
| pRB:E2F1:DP1:SWI:SNF:HDAC1 | Nucleoplasm | |
| SWI:SNF:HDAC1:SUV39H1:pRB:E2F1:DP1 | Nucleoplasm | |
| CCND1:CDK4(P@Thr172):CDKN1B | Nucleoplasm | |
| pRB:E2F1:DP1:SWI:SNF:HDAC1:SUV39H1:HP1gamma | Nucleoplasm | |
| late G1 | pRB(P):E2F1:DP1:SWI:SNF:HDAC1 | Nucleoplasm |
| pRB(P|P):E2F1:DP1:SWI:SNF | Nucleoplasm | |
| early S | CCNE1:CDK2(P@Thr160) | Nucleoplasm |
| late S | CCNA2:CDK2(P@Thr160) | Nucleoplasm |
| G2 | CCNB1:CDK1(P@Tyr15) | Cytoplasm |
| CCNB1:CDK1(P@Tyr15|P@Thr14) | Cytoplasm | |
| CCNB1:CDK1 | Cytoplasm | |
| CCNB1:CDK1(P@Thr14) | Cytoplasm | |
| M | CDC25(P) | Nucleoplasm |
| WEE1(P@Ser53) | Nucleoplasm | |
| CCNB1:CDK1(P@Thr161) | Nucleoplasm | |
| CDC20(P) | Nucleoplasm |
The markers for each phase of the cell cycle are given under a textual form. The names used to describe the markers are the labels of the corresponding entities in the map. Subunits in complexes are separated using the “:” character. Text in parantheses gives the post-translational modifications of a given entity (protein or complex subunit). For example, “P@Thr172” represents a phosphorylation at threonine 172. A same entity may have more than one post-translational modifications, separated in the text by the “|” character
Markers of the phases of the circadian clock
| Phase | Marker | Compartment |
|---|---|---|
| RORG | RORG | Nucleoplasm |
| SIRT1 | SIRT1 | Nucleoplasm |
| ARNTL-CLOCK | ARNTL(Ac@L538|P@S90):CLOCK(ADPr):CSNK2A | Nucleoplasm |
| PER-CRY | PER1:CRY1:CRY2:ARNTL(Ac@L538|P@S90): CLOCK(ADPr):PER2(Ac):CSNK1D:CSNK1E | Nucleoplasm |
The markers for each phase of the cell cycle are given under a textual form. The names used to describe the markers are the labels of the corresponding entities in the map. Subunits in complexes are separated using the “:” character. Text in parantheses gives the post-translational modifications of a given entity (protein or complex subunit). For example, “P@Thr172” represents a phosphorylation at threonine 172. A same entity may have more than one post-translational modifications, separated in the text by the “|” character
Analysis of the progression of the circadian clock
| Phase | Num. markers reachable/total |
|---|---|
| (A) Reachability of markers | |
| RORG | 1/1 |
| SIRT1 | 1/1 |
| ARNTL-CLOCK | 1/1 |
| PER-CRY | 1/1 |
We tested whether each phase of the circadian clock could be reached from each precursor state, with or without its preceding phase disabled. Results are shown for the 16 precursor states containing either NAD+ or NMN. For the eight remaining precursor states rather containing NAM, no markers were reachable. For (B) and (C), the phase is reachable if at least one of its markers is reachable. (A) Reachability of the markers of each phase (control). (B) Reachability of each phase. (C) Reachability of each phase with its preceding phase disabled
Analysis of the progression of the cell cycle
| Phase | Num. markers reachable/total |
|---|---|
| (A) Reachability of markers | |
| early G1 | 5/5 |
| late G1 | 2/2 |
| early S | 1/1 |
| late S | 1/1 |
| G2 | 4/4 |
| M | 4/4 (3/4) |
We tested whether each phase of the cell cycle could be reached from each precursor state, with or without its preceding phase disabled. Results were the same for the 24 precursor states except for one marker of phase M, which was not reachable from the eight precursor states containing NAM (shown in parantheses). For (B) and (C), the phase is reachable if at least one of its markers is reachable. (A) Reachability of the markers of each phase (control). (B) Reachability of each phase. (C) Reachability of each phase with its preceding phase disabled
Identified mutations of entities of the circadian clock controlling the reachability of at least one phase marker of a cell cycle phase
| Cell cycle phase | Circadian clock entity | Mutation |
|---|---|---|
| early G1 | HSP90 | LoF |
| late G1 | HSP90 | LoF |
| early S | ||
| late S | HSP90 | LoF |
| G2 | PER:CRY:CSNK1:CLOCK:ARNTL | GoF |
| MYC:MIZ1 | GoF | |
| WEE1 | LoF | |
| ARNTL | LoF | |
| CLOCK | LoF | |
| CSNK2A | LoF | |
| MIZ1 | LoF | |
| NAD+ | LoF | |
| PARP1 | LoF | |
| NR1D1 | GoF | |
| NMN* | LoF | |
| NMNAT* | LoF | |
| M | ||
| CCNB1:CDK1 | LoF | |
Mutations either disable an entity (LoF), or force its activity (GoF) *: only in the eight precursor states containing NMN. For G2 and M: no mutations predicted for the eight precursor states containing NAM